Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
NTD Innovation Prize voor snelle en betaalbare diagnostiek schistosomiasis
sep 2021 | Parasitaire infecties